Hamlet Pharma AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Linnane Pharma AB, was filed 29 May 2023.
Hamlet Pharma AB: what insiders have been doing
Hamlet Pharma AB is a listed company. Filings by its managers are published through Finansinspektionen. Nothing new has been filed by managers of Hamlet Pharma AB in twelve months, the latest record being from 29 May 2023.
The full history, which starts in 2017, counts 4 purchases against 1 sale.
Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
- 100,000 shares@ SEK 3.26100.0% of flowAktieISIN SE0015661145FI:csv-782e4d8a4de6424d5851Canonical exit: 24 Aug 2023 (T+90)
- 100,000 shares@ SEK 3.26100.0% of flowAktieISIN SE0015661145FI:csv-3f9385c000e5780d02e8
- 15,000 shares@ SEK 6.12100.0% of flowAktieISIN SE0015661152FI:csv-3a82c18aa9097951d696Canonical exit: 18 Apr 2022 (T+90)
- 384 shares@ SEK 13.000.0% of flowBTU (betald tecknad unit)FI:csv-96847591b76a4e353d62
- 769 shares@ SEK 13.000.0% of flowBTU (betald tecknad unit)FI:csv-d1b11aeb14c80ebf3478
- 10,000 shares@ SEK 6.500.0% of flowBTA (betald tecknad aktie)ISIN SE0016609358FI:csv-3ab45c31908e28e7e50dCanonical exit: 21 Oct 2021 (T+90)
- 10,000 shares@ SEK 60,000.00100.0% of flowFI:csv-d03e98375ab18b2d488aCanonical exit: 22 Aug 2017 (T+90)
7 of 7 declarations
About Hamlet Pharma AB
Hamlet Pharma AB is a pharmaceutical company focused on developing innovative treatments for digestive health-related diseases. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations